169 related articles for article (PubMed ID: 17657678)
1. Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.
Lee TJ; Chun JK; Yeon SI; Shin JS; Kim DS
Scand J Rheumatol; 2007; 36(3):222-5. PubMed ID: 17657678
[TBL] [Abstract][Full Text] [Related]
2. High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease.
Hoshina T; Kusuhara K; Ikeda K; Mizuno Y; Saito M; Hara T
Scand J Rheumatol; 2008; 37(6):445-9. PubMed ID: 18720262
[TBL] [Abstract][Full Text] [Related]
3. [Serum levels of pro-inflammatory cytokines in diabetic patients with peripheral neuropathic pain and the correlation among them].
Yu LN; Yang XS; Hua Z; Xie W
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):469-71. PubMed ID: 19567096
[TBL] [Abstract][Full Text] [Related]
4. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression.
Muramaki M; Miyake H; Yamada Y; Hara I
Oncol Rep; 2006 Jan; 15(1):253-7. PubMed ID: 16328065
[TBL] [Abstract][Full Text] [Related]
7. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis.
Kitaichi N; Kotake S; Sasamoto Y; Namba K; Matsuda A; Ogasawara K; Onoé K; Matsuda H; Nishihira J
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):247-50. PubMed ID: 9888451
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis.
Ren Y; Lin CL; Li Z; Chen XY; Huang X; Lui V; Nicholls J; Lan HY; Tam PK
Histopathology; 2005 Jun; 46(6):659-67. PubMed ID: 15910597
[TBL] [Abstract][Full Text] [Related]
9. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.
Willeke P; Gaubitz M; Schotte H; Maaser C; Domschke W; Schlüter B; Becker H
Arthritis Res Ther; 2007; 9(2):R43. PubMed ID: 17470266
[TBL] [Abstract][Full Text] [Related]
10. Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation.
Toubai T; Shono Y; Nishihira J; Ibata M; Suigita J; Kato N; Ohkawara T; Tone S; Lowler KP; Ota S; Tanaka J; Asaka M; Reddy P; Imamura M
Int J Lab Hematol; 2009 Apr; 31(2):161-8. PubMed ID: 18081874
[TBL] [Abstract][Full Text] [Related]
11. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
Zhang W; Yue B; Wang GQ; Lu SL
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):577-80. PubMed ID: 14607690
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia.
Todros T; Bontempo S; Piccoli E; Ietta F; Romagnoli R; Biolcati M; Castellucci M; Paulesu L
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):162-6. PubMed ID: 15894418
[TBL] [Abstract][Full Text] [Related]
13. Circulating adiponectin levels in Kawasaki disease.
Takeshita S; Takabayashi H; Yoshida N
Acta Paediatr; 2006 Oct; 95(10):1312-4. PubMed ID: 16982510
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor in systemic lupus erythematosus.
Foote A; Briganti EM; Kipen Y; Santos L; Leech M; Morand EF
J Rheumatol; 2004 Feb; 31(2):268-73. PubMed ID: 14760795
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
Popp J; Bacher M; Kölsch H; Noelker C; Deuster O; Dodel R; Jessen F
J Psychiatr Res; 2009 May; 43(8):749-53. PubMed ID: 19038405
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F
J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708
[TBL] [Abstract][Full Text] [Related]
17. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients.
Chen LC; Lei HY; Liu CC; Shiesh SC; Chen SH; Liu HS; Lin YS; Wang ST; Shyu HW; Yeh TM
Am J Trop Med Hyg; 2006 Jan; 74(1):142-7. PubMed ID: 16407359
[TBL] [Abstract][Full Text] [Related]
18. Increased serum levels of vascular endothelial growth factor in Kawasaki disease.
Maeno N; Takei S; Masuda K; Akaike H; Matsuo K; Kitajima I; Maruyama I; Miyata K
Pediatr Res; 1998 Oct; 44(4):596-9. PubMed ID: 9773852
[TBL] [Abstract][Full Text] [Related]
19. Marked elevation of serum macrophage migration inhibitory factor levels in patients with pemphigus vulgaris.
Namazi MR; Fallahzadeh MK; Shaghelani H; Kamali-Sarvestani E
Int J Dermatol; 2010 Feb; 49(2):146-8. PubMed ID: 19799642
[TBL] [Abstract][Full Text] [Related]
20. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
Tashimo A; Mitamura Y; Nagai S; Nakamura Y; Ohtsuka K; Mizue Y; Nishihira J
Diabet Med; 2004 Dec; 21(12):1292-7. PubMed ID: 15569131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]